Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Boca Raton, FL
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Boynton Beach, FL
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Celebration, FL
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Celebration, FL
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Miami, FL
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Port Saint Lucie, FL
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Port Saint Lucie, FL
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Chicago, IL
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Des Moines, IA
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Des Moines, IA
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Kansas City, KA
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Louisville, KY
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Novi, MI
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Novi, MI
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Columbia, MO
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Columbia, MO
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Lebanon, NH
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Lebanon, NH
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Charlotte, NY
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Charlotte, NY
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
New Hyde Park, NY
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
New Windsor, NY
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
New Windsor, NY
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
New York, NY
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Rochester, NY
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
White Plains, NY
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
White Plains, NY
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Matthews, NC
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Matthews, NC
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Winston-Salem, NC
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
mi
from
Havertown, PA
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
mi
from
Havertown, PA
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Charleston, SC
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
mi
from
Lugoff, SC
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
mi
from
Lugoff, SC
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Orangeburg, SC
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Nashville, TN
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Fort Sam Houston, TX
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Saint George, UT
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Saint George, UT
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Norfolk, VA
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
mi
from
Tacoma, WA
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Kelowna,
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Kelowna,
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
University of Alabama
mi
from
Birmingham, AL
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Childrens National Medical Center
mi
from
Washington,
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Children's Memorial Hospital, Chicago
mi
from
Chicago, IL
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Children's Memorial Hospital, Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Johns Hopkins Oncology Center
mi
from
Baltimore, MD
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Johns Hopkins Oncology Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Children's Hospital/Dana Farber Cancer Institute
mi
from
Boston, MA
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Children's Hospital/Dana Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Beth Israel Med Ctr
mi
from
New York, NY
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Beth Israel Med Ctr
mi
from
New York, NY
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
SUNY Upstate Medical University
mi
from
Syracuse, NY
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Cleveland Clinic
mi
from
Cleveland, OH
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Oregon Health and Sciences University
mi
from
Portland, OR
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Texas Children's Hospital
mi
from
Houston, TX
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery
Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery
Status: Enrolling
Updated:  4/19/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery
Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery
Status: Enrolling
Updated: 4/19/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias
Phase I/II Trial of VELCADE® (Bortezomib) in Combination With Mitoxantrone and Etoposide for Relapsed or Refractory Acute Leukemias
Status: Enrolling
Updated:  4/23/2018
Sidney Kimmel Cancer Center - Thomas Jefferson University
mi
from
Philadelphia, PA
Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias
Phase I/II Trial of VELCADE® (Bortezomib) in Combination With Mitoxantrone and Etoposide for Relapsed or Refractory Acute Leukemias
Status: Enrolling
Updated: 4/23/2018
Sidney Kimmel Cancer Center - Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Spectral Dynamics and Speech Understanding by Hearing Impaired People
Spectral Dynamics and Speech Understanding by Hearing Impaired People
Status: Enrolling
Updated:  4/24/2018
VA Portland Health Care System, Portland, OR
mi
from
Portland, OR
Spectral Dynamics and Speech Understanding by Hearing Impaired People
Spectral Dynamics and Speech Understanding by Hearing Impaired People
Status: Enrolling
Updated: 4/24/2018
VA Portland Health Care System, Portland, OR
mi
from
Portland, OR
Click here to add this to my saved trials